SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-029232
Filing Date
2010-03-29
Accepted
2010-03-29 10:50:04
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c98436e10vk.htm 10-K 1209932
2 EXHIBIT 21 c98436exv21.htm EX-21 796
3 EXHIBIT 23.1 c98436exv23w1.htm EX-23.1 1756
4 EXHIBIT 31.1 c98436exv31w1.htm EX-31.1 9239
5 EXHIBIT 31.2 c98436exv31w2.htm EX-31.2 9486
6 EXHIBIT 32.1 c98436exv32w1.htm EX-32.1 2930
7 EXHIBIT 32.2 c98436exv32w2.htm EX-32.2 2985
8 GRAPHIC c98436c9843601.gif GRAPHIC 13655
  Complete submission text file 0000950123-10-029232.txt   1257636
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 10709586
SIC: 2834 Pharmaceutical Preparations